Efficacy of half-dose recombinant human prourokinase thrombolysis combined with early PCI in 48 patients with ST-segment-elevation myocardial infarction (STEMI)

Asian J Surg. 2023 Apr;46(4):1658-1659. doi: 10.1016/j.asjsur.2022.09.115. Epub 2022 Oct 6.

¹ Chengde Medical University, Chengde, China.
² Department of Cardiology, Chengde Central Hospital, Second Clinical College of Chengde Medical University, Chengde, China.
³ Department of Cardiology, Chengde Central Hospital, Second Clinical College of Chengde Medical University, Chengde, China. Electronic address: 294780382@qq.com.
⁴ Department of Cardiology, Chengde Central Hospital, Second Clinical College of Chengde Medical University, Chengde, China. Electronic address: dongleiluocn@aliyun.com.

No abstract available

Keywords: Percutaneous coronary intervention; Recombinant human prourokinase; ST-Segment-elevation myocardial infarction.

Publication types